Aiyar, R. S., J. Gagneur, and L. M. Steinmetz. (2008) “Identification of Mitochondrial Disease Genes Through Integrative Analysis of Multiple Datasets.” Methods 46: 248–255.

Alderton, G. K., H. Joenje, R. Varon, A. D. Borglum, P. A. Jeggo, and M. O’Driscoll. (2004) “Seckel Syndrome Exhibits Cellular Features Demonstrating Defects in the ATR-Signalling Pathway.” Human Molecular Genetics 13: 3,127–3,138.

Allouche, M. (2007) “ALK Is a Novel Dependence Receptor: Potential Implications in Development and Cancer.” Cell Cycle 6: 1,533–1,538.

Amir, R. E., I. B. Van den Veyver, M. Wan, C. Q. Tran, U. Francke, and H. Y. Zoghbi. (1999) “Rett Syndrome Is Caused by Mutations in X-Linked MECP2, Encoding Methyl-CpG-Binding Protein 2.” Nature Genetics 23: 185–188.

Anderson, K., C. Lutz, F. W. van Delft, C. M. Bateman, Y. Guo, S. M. Colman, H. Kempski, A. V. Moorman, I. Titley, J. Swansbury, et al. (2011) Genetic Variegation of Clonal Architecture and Propagating Cells in Leukaemia.” Nature 469: 356–361.

Arai, T., M. Hasegawa, H. Akiyama, K. Ikeda, T. Nonaka, H. Mori, D. Mann, K. Tsuchiya, M. Yoshida, Y. Hashizume, et al. (2006) “TDP-43 Is a Component of Ubiquitin-Positive Tau-Negative Inclusions in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis.” Biochemical and Biophysical Research Communications 351: 602–611.

Araya, J., and S. L. Nishimura. (2010) “Fibrogenic Reactions in Lung Disease.” Annual Review of Pathology 5: 77–98.

Auffray, C., D. Charron, and L. Hood. (2010) “Predictive, Preventive, Personalized, and Participatory Medicine: Back to the Future.” Genome Medicine 2: 57.

Auffray, C., Z. Chen, and L. Hood. (2009) “Systems Medicine: The Future of Medical Genomics and Healthcare.” Genome Medicine 1: 2.

Azzedine, H., N. Ravise, C. Verny, A. Gabreels-Festen, M. Lammens, D. Grid, J. M. Vallat, G. Durosier, J. Senderek, S. Nouioua, et al. (2006) “Spine Deformities in Charcot-Marie-Tooth 4C Caused by SH3TC2 Gene Mutations.” Neurology 67: 602–606.

Azzu, V., and M. D. Brand, “The On–Off Switches of the Mitochondrial Uncoupling Proteins.” Trends in Biochemical Sciences 35: 298–307.

Bartel, D. P. (2009) “MicroRNAs: Target Recognition and Regulatory Functions.” Cell 136: 215–233.

Bassell, G. J., and S. T. Warren. (2008) “Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function.” Neuron 60: 201–214.

Baumer, D., O. Ansorge, M. Almeida, and K. Talbot. (2010) “The Role of RNA Processing in the Pathogenesis of Motor Neuron Degeneration.” Expert Reviews in Molecular Medicine 12: e21.

Bear, M. F., K. M. Huber, and S. T. Warren. (2004) “The mGluR Theory of Fragile X Mental Retardation.” Trends in Neurosciences 27: 370–377.

Beeson, J. G., and B. S. Crabb. (2007) “Towards a Vaccine Against Plasmodium Vivax Malaria.” PLoS Medicine 4: e350.

Bekker-Jensen, S., J. Rendtlew Danielsen, K. Fugger, I. Gromova, A. Nerstedt, C. Lukas, J. Bartek, J. Lukas, and N. Mailand. (2010) “HERC2 Coordinates Ubiquitin-Dependent Assembly of DNA Repair Factors on Damaged Chromosomes.” Nature Cell Biology 12: 80–86, sup. 1–12.

Belenky, P., K. L. Bogan, and C. Brenner. (2007) “NAD+ Metabolism in Health and Disease.” Trends in Biochemical Sciences 32: 12–19.

Benz, E. J., Jr. (2010) “Learning About Genomics and Disease from the Anucleate Human Red Blood Cell.” Journal of Clinical Investigation 120: 4,204–4,206.

Bernard, C. (1865) An Introduction to the Study of Experimental Medicine. Trans. by Henry Copley Greene. New York: Dover Publications, 1957.

Bilguvar, K., A. K. Ozturk, A. Louvi, K. Y. Kwan, M. Choi, B. Tatli, D. Yalnizoglu, B. Tuysuz, A. O. Caglayan, S. Gokben, et al. (2010) “Whole-Exome Sequencing Identifies Recessive WDR62 Mutations in Severe Brain Malformations.” Nature 467: 207–210.

Bird, A. (2007) “Perceptions of Epigenetics.” Nature 447: 396–398.

Birney, E., J. A. Stamatoyannopoulos, A. Dutta, R. Guigo, T. R. Gingeras, E. H. Margulies, A. Weng, M. Snyder, E. T. Dermitzakis, R. E. Thurman, et al. (2007) “Identification and Analysis of Functional Elements in 1% of the Human Genome by the ENCODE Pilot Project.” Nature 447: 799–816.

Boer, U., J. Eglins, D. Krause, S. Schnell, C. Schofl, and W. Knepel. (2007) “Enhancement by Lithium of cAMP-Induced CRE/CREB-Directed Gene Transcription Conferred by TORC on the CREB Basic Leucine Zipper Domain.” Biochemical Journal 408: 69–77.

Boggs, L. N., K. S. Fuson, M. Baez, L. Churgay, D. McClure, G. Becker, and P. C. May. (1996) “Clusterin (Apo J) Protects Against In Vitro Amyloid-Beta (1-40) Neurotoxicity.” Journal of Neurochemistry 67: 1,324–1,327.

Bolderson, E., D. J. Richard, B. B. Zhou, and K. K. Khanna. (2009) “Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair.” Clinical Cancer Research 15: 6,314–6,320.

Borg, J., P. Papadopoulos, M. Georgitsi, L. Gutierrez, G. Grech, P. Fanis, M. Phylactides, A. J. Verkerk, P. J. van der Spek, C. A. Scerri, et al. (2010) “Haploinsufficiency for the Erythroid Transcription Factor KLF1 Causes Hereditary Persistence of Fetal Hemoglobin.” Nature Genetics 42: 801–805.

Borrelli, E., E. J. Nestler, C. D. Allis, and P. Sassone-Corsi. (2008) “Decoding the Epigenetic Language of Neuronal Plasticity.: Neuron 60: 961–974.

Bozdagi, O., T. Sakurai, D. Papapetrou, X. Wang, D. L. Dickstein, N. Takahashi, Y. Kajiwara, M. Yang, A. M. Katz, M. L. Scattoni, et al. (2010) “Haploinsufficiency of the Autism-Associated Shank3 Gene Leads to Deficits in Synaptic Function, Social Interaction, and Social Communication.” Molecular Autism 1: 15.

Bu, G. (2009) “Apolipoprotein E and Its Receptors in Alzheimer’s Disease: Pathways, Pathogenesis, and Therapy.” Nature Reviews Neuroscience 10: 333–344.

Burre, J., M. Sharma, T. Tsetsenis, V. Buchman, M. R. Etherton, and T. C. Sudhof. (2010) “Alpha-Synuclein Promotes SNARE-Complex Assembly In Vivo and In Vitro.” Science 329: 1,663–1,667.

Calero, M., A. Rostagno, E. Matsubara, B. Zlokovic, B. Frangione, and J. Ghiso. (2000) “Apolipoprotein J (Clusterin) and Alzheimer’s Disease.” Microscopy Research and Technique 50: 305–315.

Campbell, P. J., S. Yachida, L. J. Mudie, P. J. Stephens, E. D. Pleasance, L. A. Stebbings, L. A. Morsberger, C. Latimer, S. McLaren, M. L. Lin, et al. (2010) “The Patterns and Dynamics of Genomic Instability in Metastatic Pancreatic Cancer.: Nature 467: 1,109–1,113.

Cantor, R. M., K. Lange, and J. S. Sinsheimer. (2010) “Prioritizing GWAS Results: A Review of Statistical Methods and Recommendations for Their Application.” American Journal of Human Genetics 86: 6–22.

Carninci, P. (2010) “RNA Dust: Where Are the Genes?” DNA Research 17: 51–59.

Caughey, B., G. S. Baron, B. Chesebro, and M. Jeffrey. (2009) “Getting a Grip on Prions: Oligomers, Amyloids, and Pathological Membrane Interactions.” Annual Review of Biochemistry 78: 177–204.

Chahal, H. S., J. P. Chapple, L. A. Frohman, A. B. Grossman, and M. Korbonits. (2010) “Clinical, Genetic, and Molecular Characterization of Patients with Familial Isolated Pituitary Adenomas (FIPA).” Trends in Endocrinology and Metabolism 21: 419–427.

Chahal, H. S., K. Stals, M. Unterlander, D. J. Balding, M. G. Thomas, A. V. Kumar, G. M. Besser, A. B. Atkinson, P. J. Morrison, T. A. Howlett, et al. (2011) “AIP Mutation in Pituitary Adenomas in the 18th Century and Today.” New England Journal of Medicine 364: 43–50.

Chahrour, M., S. Y. Jung, C. Shaw, X. Zhou, S. T. Wong, J. Qin, and H. Y. Zoghbi. (2008) “MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription.” Science 320: 1,224–1,229.

Chang, S., T. ran Ma, R. D. Miranda, M. E. Balestra, R. W. Mahley, and Y. Huang. (2005) “Lipid- and Receptor-Binding Regions of Apolipoprotein E4 Fragments Act in Concert to Cause Mitochondrial Dysfunction and Neurotoxicity.” Proceedings of the National Academy of Sciences USA 102: 18,694–18,699.

Chotivanich, K., R. Udomsangpetch, K. Pattanapanyasat, W. Chierakul, J. Simpson, S. Looareesuwan, and N. White. (2002) “Hemoglobin E: A Balanced Polymorphism Protective Against High Parasitemias and Thus Severe P Falciparum Malaria.” Blood 100: 1,172–1,176.

Christie, J. M. and G. L. Westbrook. (2006) “Lateral Excitation Within the Olfactory Bulb.” Journal of Neuroscience 26: 2,269–2,277.

Chung, E., Y. Ji, Y. Sun, R. J. Kascsak, R. B. Kascsak, P. D. Mehta, S. M. Strittmatter, and T. Wisniewski. (2010) “Anti-PrPC Monoclonal Antibody Infusion As a Novel Treatment for Cognitive Deficits in an Alzheimer’s Disease Model Mouse.” BMC Neuroscience 11: 130.

Cisse, M., and L. Mucke. (2009) “Alzheimer’s Disease: A Prion Protein Connection.” Nature 457: 1,090–1,091.

Cooke, S. F., and T. V. Bliss. (2006) “Plasticity in the Human Central Nervous System.” Brain 129: 1,659–1,673.

Costa, V., C. Angelini, I. De Feis, and A. Ciccodicola. “Uncovering the Complexity of Transcriptomes with RNA-Seq.” Journal of Biomedicine and Biotechnology 2010: 853,916.

Cruceanu, C., M. Alda, and G. Turecki. (2009) “Lithium: A Key to the Genetics of Bipolar Disorder.” Genome Medicine 1: 79.

Cuddapah, S., R. Jothi, D. E. Schones, T. Y. Roh, K. Cui, and K. Zhao. (2009) “Global Analysis of the Insulator Binding Protein CTCF in Chromatin Barrier Regions Reveals Demarcation of Active and Repressive Domains.” Genome Research 19: 24–32.

Daly A.F., M.A. Tichomirowa, P. Petrossians, E. Heliovaara, M.L Jaffrain Rea, A. Barlier, L.A. Naves, T. Eberling, A Karhu, A Raappana et al. (2010) “Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study.” Journal of Clinical Endocrinology & Metabolism 95: E373–E383.

Dauwerse, J. G., J. Dixon, S. Seland, C. A. Ruivenkamp, A. van Haeringen, L. H. Hoefsloot, D. J. Peters, A. C. Boers, C. Daumer-Haas, R. Maiwald, et al (2010). “Mutations in Genes Encoding Subunits of RNA Polymerases I and III Cause Treacher Collins Syndrome.” Nature Genetics 43: 20–22.

de Bono, J. S., and A. Ashworth. (2010) “Translating Cancer Research into Targeted Therapeutics.” Nature 467: 543–549.

de Oliveira, R. M., T. F. Pais, and T. F. Outeiro. (2010) “Sirtuins: Common Targets in Aging and in Neurodegeneration.” Current Drug Targets 11: 1,270–1,280.

De Strooper, B., R. Vassar, and T. Golde. (2010) “The Secretases: Enzymes with Therapeutic Potential in Alzheimer Disease.” Nature Reviews Neurology 6: 99–107.

Deng, H. X., H. Zhai, E. H. Bigio, J. Yan, F. Fecto, K. Ajroud, M. Mishra, S. Ajroud-Driss, S. Heller, R. Sufit, et al. (2010) “FUS-Immunoreactive Inclusions Are a Common Feature in Sporadic and Non-SOD1 Familial Amyotrophic Lateral Sclerosis.” Annals of Neurology 67: 739–748.

Derheimer, F. A., and M. B. Kastan. (2010) “Multiple Roles of ATM in Monitoring and Maintaining DNA Integrity.” FEBS Letters 584: 3,675–3,681.

Dias-Santagata, D., S. Akhavanfard, S. S. David, K. Vernovsky, G. Kuhlmann, S. L. Boisvert, H. Stubbs, U. McDermott, J. Settleman, E. L. Kwak, et al. (2010) “Rapid Targeted Mutational Analysis of Human Tumours: A Clinical Platform to Guide Personalized Cancer Medicine.” EMBO Molecular Medicine 2: 146–158.

Dietrich, M. O., and T. L. Horvath. (2010) “The Role of Mitochondrial Uncoupling Proteins in Lifespan.” Pflugers Archives 459: 269–275.

Donmez, G., D. Wang, D. E. Cohen, and L. Guarente. (2010) “SIRT1 Suppresses Beta-Amyloid Production by Activating the Alpha-Secretase Gene ADAM10.” Cell 142: 320–332.

Duvel, K., J. L. Yecies, S. Menon, P. Raman, A. I. Lipovsky, A. L. Souza, E. Triantafellow, Q. Ma, R. Gorski, S. Cleaver, et al. (2010) “Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1.” Molecular Cell 39: 171–183.

Echtay, K. S., D. Roussel, J. St-Pierre, M. B. Jekabsons, S. Cadenas, J. A. Stuart, J. A. Harper, S. J. Roebuck, A. Morrison, S. Pickering, et al. (2002) “Superoxide Activates Mitochondrial Uncoupling Proteins.” Nature 415: 96–99.

Eckel-Mahan, K., and P. Sassone-Corsi. (2010) “Aging Brains and Waning Clocks on the Process of Habituation.” Aging 2: 320–321.

Ehehalt, R., P. Keller, C. Haass, C. Thiele, and K. Simons. (2003) “Amyloidogenic Processing of the Alzheimer Beta-Amyloid Precursor Protein Depends on Lipid Rafts.” Journal of Cell Biology 160: 113–123.

Fagan, A. M., D. Head, A. R. Shah, D. Marcus, M. Mintun, J. C. Morris, and D. M. Holtzman. (2009) “Decreased Cerebrospinal Fluid Abeta(42) Correlates with Brain Atrophy in Cognitively Normal Elderly.” Annals of Neurology 65: 176–183.

Fazzari, P., A. V. Paternain, M. Valiente, R. Pla, R. Lujan, K. Lloyd, J. Lerma, O. Marin, and B. Rico. (2010) “Control of Cortical GABA Circuitry Development by Nrg1 and ErbB4 Signalling.” Nature 464: 1,376–1,380.

Feng, Y., C. A. Gutekunst, D. E. Eberhart, H. Yi, S. T. Warren, and S. M. Hersch. (1997) “Fragile X Mental Retardation Protein: Nucleocytoplasmic Shuttling and Association with Somatodendritic Ribosomes.” Journal of Neuroscience 17: 1,539–1,547.

Ferry, G. (2009) “Science’s New Battle Lines.” Nature 459: 34–35.

Firestein, R., A. J. Bass, S. Y. Kim, I. F. Dunn, S. J. Silver, I. Guney, E. Freed, A. H. Ligon, N. Vena, S. Ogino, et al. (2008) “CDK8 Is a Colorectal CVancer Oncogene That Regulates Beta-Catenin Activity.” Nature 455: 547–551.

Fischer, A., F. Sananbenesi, A. Mungenast, and L. H. Tsai. (2010) “Targeting the Correct HDAC(s) to Treat Cognitive Disorders.” Trends in Pharmacological Sciences 31: 605–617.

Flaherty, K. T., I. Puzanov, K. B. Kim, A. Ribas, G. A. McArthur, J. A. Sosman, P. J. O’Dwyer, R. J. Lee, J. F. Grippo, K. Nolop, et al. (2010) “Inhibition of Mutated, Activated BRAF in Metastatic Melanoma.” New England Journal of Medicine 363: 809–819.

Fong, P. C., D. S. Boss, T. A. Yap, A. Tutt, P. Wu, M. Mergui-Roelvink, P. Mortimer, H. Swaisland, A. Lau, M. J. O’Connor, et al. (2009) “Inhibition of Poly(ADP-ribose) Polymerase in Tumors from BRCA Mutation Carriers.” New England Journal of Medicine 361: 123–134.

Forero, D. A., K. van der Ven, P. Callaerts, and J. Del-Favero. (2010) “miRNA Genes and the Brain: Implications for Psychiatric Disorders.” Human Mutation 31: 1,195–1,204.

Forlani, G., E. Giarda, U. Ala, F. Di Cunto, M. Salani, R. Tupler, C. Kilstrup-Nielsen, and N. Landsberger. (2010) “The MeCP2/YY1 Interaction Regulates ANT1 Expression at 4q35: Novel Hints for Rett Syndrome Pathogenesis.” Human Molecular Genetics 19: 3,114–3,123.

Frost, B., and M. I. Diamond. (2010) “Prion-like Mechanisms in Neurodegenerative Diseases.” Nature Reviews Neuroscience 11: 155–159.

Fukata, Y., and M. Fukata. (2010) “Protein Palmitoylation in Neuronal Development and Synaptic Plasticity.” Nature Reviews Neuroscience 11: 161–175.

Gabellini, D., M. R. Green, and R. Tupler. (2002) “Inappropriate Gene Activation in FSHD: A Repressor Complex Binds a Chromosomal Repeat Deleted in Dystrophic Muscle.” Cell 110: 339–348.

Gallagher, P. G., L. A. Steiner, R. I. Liem, A. N. Owen, A. P. Cline, N. E. Seidel, L. J. Garrett, and D. M. Bodine. (2010) “Mutation of a Barrier Insulator in the Human Ankyrin-1 Gene Is Associated with Hereditary Spherocytosis.” Journal of Clinical Investigation 120: 4,453–4,465.

Gao, J., W. Y. Wang, Y. W. Mao, J. Graff, J. S. Guan, L. Pan, G. Mak, D. Kim, S. C. Su, and L. H. Tsai. (2010) “A Novel Pathway Regulates Memory and Plasticity via SIRT1 and miR-134.” Nature 466: 1,105–1,109.

Garber, K. (2010) “ALK, Lung Cancer, and Personalized Therapy: Portent of the Future?: Journal of the National Cancer Institute 102: 672–675.

Garcia-Arocena, D., and P. J. Hagerman. “Advances in Understanding the Molecular Basis of FXTAS.” (2010) Human Molecular Genetics 19: R83–R89.

Garner, C., T. Tatu, J. E. Reittie, T. Littlewood, J. Darley, S. Cervino, M. Farrall, P. Kelly, T. D. Spector, and S. L. Thein. (2000) “Genetic Influences on F Cells and Other Hematologic Variables: A Twin Heritability Study.” Blood 95: 342–346.

Ghaemmaghami, S., B. C. May, A. R. Renslo, and S. B. Prusiner. (2010) “Discovery of 2-aminothiazoles As Potent Antiprion Compounds.” Journal of Virology 84: 3,408–3,412.

Gibson, P., Y. Tong, G. Robinson, M. C. Thompson, D. S. Currle, C. Eden, T. A. Kranenburg, T. Hogg, H. Poppleton, J. Martin, et al. (2010) “Subtypes of Medulloblastoma Have Distinct Developmental Origins.” Nature 468: 1,095–1,099.

Gibson, J., N. E. Morton, and A. Collins. (2006) “Extended Tracts of Homozygosity in Outbred Human Populations.” Human Molecular Genetics 15: 789–795.

Giles, K. E., H. Gowher, R. Ghirlando, C. Jin, and G. Felsenfeld. (2010) “Chromatin Boundaries, Insulators, and Long-Range Interactions in the Nucleus.” Cold Spring Harbor Symposia on Quantitative Biology (in press).

Gimbel, D. A., H. B. Nygaard, E. E. Coffey, E. C. Gunther, J. Lauren, Z. A. Gimbel, and S. M. Strittmatter. (2010) “Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein.” Journal of Neuroscience 30: 6,367–6,374.

Gingeras, T. R. (2007) “Origin of Phenotypes: Genes and Transcripts.” Genome Research 17: 682–690.

Ginsburg, G. S., and H. F. Willard. (2009) “Genomic and Personalized Medicine: Foundations and Applications.” Translational Research 154: 277–287.

Girirajan, S., and E. E. Eichler. (2010) “Phenotypic Variability and Genetic Susceptibility to Genomic Disorders.” Human Molecular Genetics 19: R176–187.

Goedert, M., F. Clavaguera, and M. Tolnay. (2010) “The Propagation of Prion-like Protein Inclusions in Neurodegenerative Diseases.” Trends in Neurosciences 33: 317–325.

Gohil, V. M., N. Offner, J. A. Walker, S. A. Sheth, E. Fossale, J. F. Gusella, M. E. MacDonald, C. Neri, and V. K. Mootha. (2011) “Meclizine Is Neuroprotective in Models of Huntington’s Disease.” Human Molecular Genetics 20: 294–300.

Gouagna, L. C., G. Bancone, F. Yao, B. Yameogo, K. R. Dabire, C. Costantini, J. Simpore, J. B. Ouedraogo, and D. Modiano. (2010) “Genetic Variation in Human HBB Is Associated with Plasmodium Falciparum Transmission.” Nature Genetics 42: 328–331.

Green, R. E., J. Krause, A. W. Briggs, T. Maricic, U. Stenzel, M. Kircher, N. Patterson, H. Li, W. Zhai, M. H. Fritz, et al. (2010) “A Draft Sequence of the Neandertal Genome.” Science 328: 710–722.

Green, A. J., M. Smith, and J. R. Yates. (1994) “Loss of Heterozygosity on Chromosome 16p13.3 in Hamartomas from Tuberous Sclerosis Patients.” Nature Genetics 6: 193–196.

Greer, P. L., R. Hanayama, B. L. Bloodgood, A. R. Mardinly, D. M. Lipton, S. W. Flavell, T. K. Kim, E. C. Griffith, Z. Waldon, R. Maehr, et al. (2010) “The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc.” Cell 140: 704–716.

Gregg, C., J. Zhang, B. Weissbourd, S. Luo, G. P. Schroth, D. Haig, and C. Dulac. (2010) “High-Resolution Analysis of Parent-of-Origin Allelic Expression in the Mouse Brain.” Science 329: 643–648.

Griffith, E., S. Walker, C. A. Martin, P. Vagnarelli, T. Stiff, B. Vernay, N. Al Sanna, A. Saggar, B. Hamel, W. C. Earnshaw, et al. (2008) “Mutations in Pericentrin Cause Seckel Syndrome with Defective ATR-Dependent DNA Damage Signaling.” Nature Genetics 40: 232–236.

Grosgen, S., M. O. Grimm, P. Friess, and T. Hartmann. (2010) “Role of Amyloid Beta in Lipid Homeostasis.” Biochimica et Biophysica Acta 1,801: 966–974.

Gu, Z., T. Nakamura, and S. A. Lipton. (2010) “Redox Reactions Induced by Nitrosative Stress Mediate Protein Misfolding and Mitochondrial Dysfunction in Neurodegenerative Diseases.” Molecular Neurobiology 41: 55–72.

Guttman, M., I. Amit, M. Garber, C. French, M. F. Lin, D. Feldser, M. Huarte, O. Zuk, B. W. Carey, J. P. Cassady, et al. (2009) “Chromatin Signature Reveals over a Thousand Highly Conserved Large Non-coding RNAs in Mammals.” Nature 458: 223–227.

Hagerman, P. J., and R. J. Hagerman. (2004) “The Fragile-X Premutation: A Maturing Perspective.” American Journal of Human Genetics 74: 805–816.

Hahn, H., C. Wicking, P. G. Zaphiropoulous, M. R. Gailani, S. Shanley, A. Chidambaram, I. Vorechovsky, E. Holmberg, A. B. Unden, S. Gillies, et al. (1996) “Mutations of the Human Homolog of Drosophila Patched in the Nevoid Basal Cell Carcinoma Syndrome.” Cell 85: 841–851.

Halfmann, R., and S. Lindquist. (2010) “Epigenetics in the Extreme: Prions and the Inheritance of Environmentally Acquired Traits.” Science 330: 629–632.

Halfmann, R., S. Alberti, and S. Lindquist. (2010) “Prions, Protein Homeostasis, and Phenotypic Diversity.” Trends in Cell Biology 20: 125–133.

Hallegger, M., M. Llorian, and C. W. Smith. (2010) “Alternative Splicing: Global Insights.” FEBS Journal 277: 856–866.

Hameroff, S. (2010) “The ‘Conscious Pilot’: Dendritic Synchrony Moves Through the Brain to Mediate Consciousness.” Journal of Biological Physics 36: 71–93.

Hansen, J. C., R. P. Ghosh, and C. L. Woodcock. (2010) “Binding of the Rett Syndrome Protein, MeCP2, to Methylated and Unmethylated DNA and Chromatin.” IUBMB Life 62: 732–738.

Hardingham, G. E., and S. A. Lipton. (2010) “Regulation of Neuronal Oxidative and Nitrosative Stress by Endogenous Protective Pathways and by Disease Processes.” Antioxidants and Redox Signaling (in press).

Hardy, S., P. E. Jacques, N. Gevry, A. Forest, M. E. Fortin, L. Laflamme, L. Gaudreau, and F. Robert. (2009) “The Euchromatic and Heterochromatic Landscapes Are Shaped by Antagonizing Effects of Transcription on H2A.Z Deposition.” PLoS Genetics 5: e1,000,687.

Harold, D., R. Abraham, P. Hollingworth, R. Sims, A. Gerrish, M. L. Hamshere, J. S. Pahwa, V. Moskvina, K. Dowzell, A. Williams, et al. (2009) “Genome-wide Association Study Identifies Variants at CLU and PICALM Associated with Alzheimer’s Disease.” Nature Genetics 41: 1,088–1,093.

Hasumi, Y., M. Baba, R. Ajima, H. Hasumi, V. A. Valera, M. E. Klein, D. C. Haines, M. J. Merino, S. B. Hong, T. P. Yamaguchi, et al. (2009) “Homozygous Loss of BHD Causes Early Embryonic Lethality and Kidney Tumor Development with Activation of mTORC1 and mTORC2.” Proceedings of the National Academy of Sciences USA 106: 18,722–18,727.

Heinrich, M. C., and C. L. Corless. (2010) “Cancer: Oncogenes in Context.” Nature 467: 796–797.

Hernandez, D. G., M. A. Nalls, J. R. Gibbs, S. Arepalli, M. van der Brug, S. Chong, M. Moore, D. L. Longo, M. R. Cookson, B. J. Traynor, et al. (2011) “Distinct DNA Methylation Changes Highly Correlated with Chronological Age in the Human Brain.” Human Molecular Genetics 20(6):1164-7

Ho, L., and G. R. Crabtree (2010) “Chromatin Remodelling During Development.” Nature 463: 474–484.

Hoeffer, C. A., and E. Klann. “mTOR Signaling: At the Crossroads of Plasticity, Memory, and Disease.” Trends in Neurosciences 33: 67–75.

Holtzman, D. M. (2004) “In Vivo Effects of ApoE and Clusterin on Amyloid-beta Metabolism and Neuropathology.” Journal of Molecular Neuroscience 23: 247–254.

Hong, S. B., H. Oh, V. A. Valera, J. Stull, D. T. Ngo, M. Baba, M. J. Merino, W. M. Linehan, and L. S. Schmidt. (2010) “Tumor Suppressor FLCN Inhibits Tumorigenesis of a FLCN-Null Renal Cancer Cell Line and Regulates Expression of Key Molecules in TGF-Beta Signaling.” Molecular Cancer 9: 160.

Hood, L., L. Rowen, D. J. Galas, and J. D. Aitchison. (2008) “Systems Biology at the Institute for Systems Biology.” Briefings in Functional Genomics Proteomic 7: 239–248.

Hooshmand, B., A. Solomon, I. Kareholt, J. Leiviska, M. Rusanen, S. Ahtiluoto, B. Winblad, T. Laatikainen, H. Soininen, and M. Kivipelto. (2010) “Homocysteine and Holotranscobalamin and the Risk of Alzheimer Disease: A Longitudinal Study.” Neurology 75: 1,408–1,414.

Houlden, H., M. Laura, L. Ginsberg, H. Jungbluth, S. A. Robb, J. Blake, S. Robinson, R. H. King, and M. M. Reilly. (2009) “The Phenotype of Charcot-Marie-Tooth Disease Type 4C Due to SH3TC2 Mutations and Possible Predisposition to an Inflammatory Neuropathy.” Neuromuscular Disorders 19: 264–269.

Huang, Y. (2010) “Abeta-Independent Roles of Apolipoprotein E4 in the Pathogenesis of Alzheimer’s Disease.” Trends in Molecular Medicine 16: 287–294.

Huang, J., and B. D. Manning. (2009) “A Complex Interplay Between Akt, TSC2, and the Two mTOR Complexes.” Biochemical Societies Transactions 37: 217–222.

Hudry, E., D. Van Dam, W. Kulik, P. P. De Deyn, F. S. Stet, O. Ahouansou, A. Benraiss, A. Delacourte, P. Bougneres, P. Aubourg, et al. (2010) “Adeno-Associated Virus Gene Therapy with Cholesterol 24-hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer’s Disease.” Molecular Therapy 18: 44–53.

Hussain, N. K., and M. Sheng. (2005) “Neuroscience. Making Synapses: A Balancing Act.” Science 307: 1,207–1,208.

Hutt, D. M., E. T. Powers, and W. E. Balch. (2009) “The Proteostasis Boundary in Misfolding Diseases of Membrane Traffic.” FEBS Letters 583: 2,639–2,646.

Illingworth, R., A. Kerr, D. Desousa, H. Jorgensen, P. Ellis, J. Stalker, D. Jackson, C. Clee, R. Plumb, J. Rogers, et al. (2008) “A Novel CpG Island Set Identifies Tissue-Specific Methylation at Developmental Gene Loci.” PLoS Biology 6: e22.

Illingworth, R. S., and A. P. Bird. (2009) “CpG Islands—‘a Rough Guide.’ FEBS Letters 583: 1,713–1,720.

Inoki, K., M. N. Corradetti, and K. L. Guan. (2005) “Dysregulation of the TSC-mTOR Pathway in Human Disease.” Nature Genetics 37: 19–24.

Ito, M., M. Hanaoka, Y. Droma, O. Hatayama, E. Sato, Y. Katsuyama, K. Fujimoto, and M. Ota. (2008) “The Association of Transforming Growth Factor Beta 1 Gene Polymorphisms with the Emphysema Phenotype of COPD in Japanese.” Internal Medicine 47: 1,387–1,394.

Itzhaki, I., L. Maizels, I. Huber, L. Zwi-Dantsis, O. Caspi, A. Winterstern, O. Feldman, A. Gepstein, G. Arbel, H. Hammerman, et al. (2011) “Modelling the Long QT Syndrome with Induced Pluripotent Stem Cells.” Nature (in press).

Iwata, N., S. Tsubuki, Y. Takaki, K. Shirotani, B. Lu, N. P. Gerard, C. Gerard, E. Hama, H. J. Lee, and T. C. Saido. (2001) “Metabolic Regulation of Brain Abeta by Neprilysin.” Science 292: 1,550–1,552.

Jackson, S. P., and J. Bartek. (2009) “The DNA-Damage Response in Human Biology and Disease.” Nature 461: 1,071–1,078.

Jennings, J., M. Georgitsi, I. Holdaway, A. Daly, M. Tichomirowa, L. Aaltonen, A. Karhu, and F. Cameron. (2009) “Aggressive Pituitary Adenomas in Young Patients in a Large Polynesian Kindred with Germline R271W Mutation in the AIP Gene.” European Journal of Endocrinology 161: 799–804.

Johannessen, C. M., J. S. Boehm, S. Y. Kim, S. R. Thomas, L. Wardwell, L. A. Johnson, C. M. Emery, N. Stransky, A. P. Cogdill, J. Barretina, et al. (2010) “COT Drives Resistance to RAF Inhibition Through MAP Kinase Pathway Reactivation.” Nature 468: 968–972.

Jones, S., T. L. Wang, M. Shih Ie, T. L. Mao, K. Nakayama, R. Roden, R. Glas, D. Slamon, L. A. Diaz Jr., B. Vogelstein, et al. (2010) “Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma.” Science 330: 228–231.

Jones, S., X. Zhang, D. W. Parsons, J. C. Lin, R. J. Leary, P. Angenendt, P. Mankoo, H. Carter, H. Kamiyama, A. Jimeno, et al. (2008) “Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses.” Science 321: 1,801–1,806.

Kahle, P. J., J. Waak, and T. Gasser. (2009) “DJ-1 and Prevention of Oxidative Stress in Parkinson’s Disease and Other Age-Related Disorders.” Free Radical Biology & Medicine 47: 1,354–1,361.

Kalay, E., G. Yigit, Y. Aslan, K. E. Brown, E. Pohl, L. S. Bicknell, H. Kayserili, Y. Li, B. Tuysuz, G. Nurnberg, et al. (2010) “CEP152 Is a Genome Maintenance Protein Disrupted in Seckel Syndrome.” Nature Genetics 43: 23–26.

Karhu, A., and L. A. Aaltonen. (2007) “Susceptibility to Pituitary Neoplasia Related to MEN-1, CDKN1B, and AIP Mutations: An Update.” Human Molecular Genetics 16 spec. no. 1: R73–R79.

Kasuki Jomori de Pinho, L., L. Vieira Neto, L. E. Armondi Wildemberg, E. L. Gasparetto, J. Marcondes, B. de Almeida Nunes, C. M. Takiya, and M. R. Gadelha. (2010) “Low Aryl Hydrocarbon Receptor-Interacting Protein Expression Is a Better Marker of Invasiveness in Somatotropinomas Than Ki-67 and p53.” Neuroendocrinology (in press).

Katayama, F., H. Miura, and S. Takanashi. (2002) “Long-Term Effectiveness and Side Effects of Acetazolamide As an Adjunct to Other Anticonvulsants in the Treatment of Refractory Epilepsies.” Brain and Development 24: 150–154.

Kathiresan, S., O. Melander, D. Anevski, C. Guiducci, N. P. Burtt, C. Roos, J. N. Hirschhorn, G. Berglund, B. Hedblad, L. Groop, et al. (2008) “Polymorphisms Associated with Cholesterol and Risk of Cardiovascular Events.” New England Journal of Medicine 358: 1,240–1,249.

Katiyar, S., E. Liu, C. A. Knutzen, E. S. Lang, C. R. Lombardo, S. Sankar, J. I. Toth, M. D. Petroski, Z. Ronai, and G. G. Chiang. (2009) “REDD1, an Inhibitor of mTOR Signalling, Is Regulated by the CUL4A-DDB1 Ubiquitin Ligase.” EMBO Reports 10: 866–872.

Kee, Y., and A. D. D’Andrea. (2010) “Expanded Roles of the Fanconi Anemia Pathway in Preserving Genomic Stability.” Genes & Development 24: 1,680–1,694.

Khatri, S., H. Yepiskoposyan, C. A. Gallo, P. Tandon, and D. R. Plas. (2010) “FOXO3a Regulates Glycolysis Via Transcriptional Control of Tumor Suppressor TSC1.” Journal of Biological Chemistry 285: 15,960–15,965.

Kilpinen, H., T. Ylisaukko-oja, K. Rehnstrom, E. Gaal, J. A. Turunen, E. Kempas, L. von Wendt, T. Varilo, and L. Peltonen. (2009) “Linkage and Linkage Disequilibrium Scan for Autism Loci in an Extended Pedigree from Finland.” Human Molecular Genetics 18: 2,912–2,921.

Kim, E., and M. Sheng. (2009) “The Postsynaptic Density.” Current Biology 19: R723–R724.

Kjolby, M., O. M. Andersen, T. Breiderhoff, A. W. Fjorback, K. M. Pedersen, P. Madsen, P. Jansen, J. Heeren, T. E. Willnow, and A. Nykjaer. (2010) “Sort1, Encoded by the Cardiovascular Risk Locus 1p13.3, Is a Regulator of Hepatic Lipoprotein Export.” Cell Metabolism 12: 213–223.

Kool, M., J. Koster, J. Bunt, N. E. Hasselt, A. Lakeman, P. van Sluis, D. Troost, N. S. Meeteren, N. H. Caron, J. Cloos, et al. (2008) “Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures, and Clinicopathological Features.” PLoS ONE 3: e3,088.

Korade, Z., and A. K. Kenworthy. (2008) “Lipid Rafts, Cholesterol, and the Brain.” Neuropharmacology 55: 1,265–1,273.

Kraytsberg, Y., E. Kudryavtseva, A. C. McKee, C. Geula, N. W. Kowall, and K. Khrapko. (2006) “Mitochondrial DNA Deletions Are Abundant and Cause Functional Impairment in Aged Human Substantia Nigra Neurons.” Nature Genetics 38: 518–520.

Kreeger, P. K., Y. Wang, K. M. Haigis, and D. A. Lauffenburger. (2010) “Integration of Multiple Signaling Pathway Activities Resolves K-RAS/N-RAS Mutation Paradox in Colon Epithelial Cell Response to Inflammatory Cytokine Stimulation.” Integrative Biology (Cambridge) Integr Biol (Camb) 2: 202–208.

Kreeger, P. K., and D. A. Lauffenburger. (2010) “Cancer Systems Biology: A Network Modeling Perspective.” Carcinogenesis 31: 2–8.

Kriaucionis, S., and N. Heintz. (2009) “The Nuclear DNA Base 5-hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain.” Science 324: 929–930.

Kuzumaki, N., D. Ikegami, R. Tamura, T. Sasaki, K. Niikura, M. Narita, K. Miyashita, S. Imai, H. Takeshima, T. Ando, et al. (2010) “Hippocampal Epigenetic Modification at the Doublecortin Gene Is Involved in the Impairment of Neurogenesis with Aging.” Synapse 64: 611–616.

Kuzumaki, N., D. Ikegami, R. Tamura, N. Hareyama, S. Imai, M. Narita, K. Torigoe, K. Niikura, H. Takeshima, T. Ando, et al. (2011) “Hippocampal Epigenetic Modification at the Brain-Derived Neurotrophic Factor Gene Induced by an Enriched Environment.” Hippocampus 21(2):127-32

Kwiatkowski, D. P. (2005) “How Malaria Has Affected the Human Genome and What Human Genetics Can Teach Us About Malaria.” American Journal of Human Genetics 77: 171–192.

Kwiatkowski, T. J., Jr., D. A. Bosco, A. L. Leclerc, E. Tamrazian, C. R. Vanderburg, C. Russ, A. Davis, J. Gilchrist, E. J. Kasarskis, T. Munsat, et al. (2009) “Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis.” Science 323: 1,205–1,208.

Lage, K., E. O. Karlberg, Z. M. Storling, P. I. Olason, A. G. Pedersen, O. Rigina, A. M. Hinsby, Z. Tumer, F. Pociot, N. Tommerup, et al. (2007) “A Human Phenome-Interactome Network of Protein Complexes Implicated in Genetic Disorders.” Nature Biotechnology 25: 309–316.

Lagier-Tourenne, C., M. Polymenidou, and D. W. Cleveland. (2010) “TDP-43 and FUS/TLS: Emerging Roles in RNA Processing and Neurodegeneration.” Human Molecular Genetics 19: R46–R64.

Lagier-Tourenne, C., and D. W. Cleveland. (2009) “Rethinking ALS: The FUS About TDP-43.” Cell 136: 1,001–1,004.

Lambert, J. C., S. Schraen-Maschke, F. Richard, N. Fievet, O. Rouaud, C. Berr, J. F. Dartigues, C. Tzourio, A. Alperovitch, L. Buee, et al. (2009) “Association of Plasma Amyloid Beta with Risk of Dementia: The Prospective Three-City Study.” Neurology 73: 847–853.

Lauren, J., D. A. Gimbel, H. B. Nygaard, J. W. Gilbert, and S. M. Strittmatter. (2009) “Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-beta Oligomers.” Nature 457: 1,128–1,132.

Law, M. J., K. M. Lower, H. P. Voon, J. R. Hughes, D. Garrick, V. Viprakasit, M. Mitson, M. De Gobbi, M. Marra, A. Morris, et al. (2010) “ATR-X Syndrome Protein Targets Tandem Repeats and Influences Allele-Specific Expression in a Size-Dependent Manner.” Cell 143: 367–378.

Leoni, V., A. Solomon, and M. Kivipelto. (2010) “Links Between ApoE, Brain Cholesterol Metabolism, Tau, and Amyloid Beta-peptide in Patients with Cognitive Impairment.” Biochemical Society Transactions 38: 1,021–1,025.

Li, T., H. Stefansson, E. Gudfinnsson, G. Cai, X. Liu, R. M. Murray, V. Steinthorsdottir, D. Januel, V. G. Gudnadottir, H. Petursson, et al. (2004) “Identification of a Novel Neuregulin 1 At-risk Haplotype in Han Schizophrenia Chinese Patients, but No Association with the Icelandic/Scottish Risk Haplotype.” Molecular Psychiatry 9: 698–704.

Li, J. Z., D. M. Absher, H. Tang, A. M. Southwick, A. M. Casto, S. Ramachandran, H. M. Cann, G. S. Barsh, M. Feldman, L. L. Cavalli-Sforza, et al. (2008) “Worldwide Human Relationships Inferred from Genome-wide Patterns of Variation.” Science 319: 1,100–1,104.

Lin, M. T., and M. F. Beal. (2006) “Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases.” Nature 443: 787–795.

Linehan, W. M., R. Srinivasan, and L. S. Schmidt. (2010) “The Genetic Basis of Kidney Cancer: A Metabolic Disease.” Nature Reviews Urology 7: 277–285.

Linsel-Nitschke, P., N. J. Samani, and H. Schunkert. (2010) “Sorting Out Cholesterol and Coronary Artery Disease.” New England Journal of Medicine 363: 2,462–2,463.

Loewer, S., M. N. Cabili, M. Guttman, Y. H. Loh, K. Thomas, I. H. Park, M. Garber, M. Curran, T. Onder, S. Agarwal, et al. (2010) “Large Intergenic Non-coding RNA-RoR Modulates Reprogramming of Human Induced Pluripotent Stem Cells.” Nature Genetics 42: 1,113–1,117.

Lord, C. J., and A. Ashworth. (2010) “Biology-Driven Cancer Drug Development: Back to the Future.” BMC Biology 8: 38.

Lupo, V., M. I. Galindo, D. Martinez-Rubio, T. Sevilla, J. J. Vilchez, F. Palau, and C. Espinos. (2009) “Missense Mutations in the SH3TC2 Protein Causing Charcot-Marie-Tooth Disease Type 4C Affect Its Localization in the Plasma Membrane and Endocytic Pathway.” Human Molecular Genetics 18: 4,603–4,614.

Lupski, J. R., J. G. Reid, C. Gonzaga-Jauregui, D. Rio Deiros, D. C. Chen, L. Nazareth, M. Bainbridge, H. Dinh, C. Jing, D. A. Wheeler, et al. (2010) “Whole-Genome Sequencing in a Patient with Charcot-Marie-Tooth Neuropathy.” New England Journal of Medicine 362: 1,181–1,191.

Ma, X. M., and J. Blenis. (2009) “Molecular Mechanisms of mTOR-Mediated Translational Control.” Nature Reviews Molecular Cell Biology 10: 307–318.

Mahley, R. W., K. H. Weisgraber, and Y. Huang. (2006) “Apolipoprotein E4: A Causative Factor and Therapeutic Target in Neuropathology, Including Alzheimer’s Disease.” Proceedings of the National Academy of Sciences USA 103: 5,644–5,651.

Maier, A. G., M. T. Duraisingh, J. C. Reeder, S. S. Patel, J. W. Kazura, P. A. Zimmerman, and A. F. Cowman. (2003) “Plasmodium Falciparum Erythrocyte Invasion Through Glycophorin C and Selection for Gerbich Negativity in Human Populations.” Nature Medicine 9: 87–92.

Marchetto, M. C., B. Winner, and F. H. Gage. (2010) “Pluripotent Stem Cells in Neurodegenerative and Neurodevelopmental Diseases.” Human Molecular Genetics 19: R71–R76.

Marian, C. O., S. K. Cho, B. M. McEllin, E. A. Maher, K. J. Hatanpaa, C. J. Madden, B. E. Mickey, W. E. Wright, J. W. Shay, and R. M. Bachoo. (2010) “The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth.” Clinical Cancer Research 16: 154–163.

Marques-Bonet, T., and E. E. Eichler. (2009) “The Evolution of Human Segmental Duplications and the Core Duplicon Hypothesis.” Cold Spring Harbor Symposia on Quantitative Biology 74: 355–362.

Martin-Broto, J., L. Rubio, R. Alemany, and J. A. Lopez-Guerrero. (2010) “Clinical Implications of KIT and PDGFRA Genotyping in GIST.” Clinical and Translational Oncology 12: 670–676.

McBride, D. J., A. K. Orpana, C. Sotiriou, H. Joensuu, P. J. Stephens, L. J. Mudie, E. Hamalainen, L. A. Stebbings, L. C. Andersson, A. M. Flanagan, et al. (2010) “Use of Cancer-Specific Genomic Rearrangements to Quantify Disease Burden in Plasma from Patients with Solid Tumors.” Genes, Chromosomes and Cancer 49: 1,062–1,069.

McCarthy, M. I. (2010) “Genomics, Type 2 Diabetes, and Obesity.” New England Journal of Medicine 363: 2,339–2,350.

McFate, T., A. Mohyeldin, H. Lu, J. Thakar, J. Henriques, N. D. Halim, H. Wu, M. J. Schell, T. M. Tsang, O. Teahan, et al. (2008) “Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer Cells.” Journal of Biological Chemistry 283: 22,700–22,708.

Mercer, T. R., M. E. Dinger, and J. S. Mattick. (2009) “Long Non-coding RNAs: Insights into Functions.” Nature Reviews Genetics 10: 155–159.

Millecamps, S., F. Salachas, C. Cazeneuve, P. Gordon, B. Bricka, A. Camuzat, L. Guillot-Noel, O. Russaouen, G. Bruneteau, P. F. Pradat, et al. (2010) “SOD1, ANG, VAPB, TARDBP, and FUS Mutations in Familial Amyotrophic Lateral Sclerosis: Genotype–Phenotype Correlations.” Journal of Medical Genetics 47: 554–560.

Montgomery, S. B., M. Sammeth, M. Gutierrez-Arcelus, R. P. Lach, C. Ingle, J. Nisbett, R. Guigo, and E. T. Dermitzakis. (2010) “Transcriptome Genetics Using Second Generation Sequencing in a Caucasian Population.” Nature 464: 773–777.

Mootha, V. K., P. Lepage, K. Miller, J. Bunkenborg, M. Reich, M. Hjerrild, T. Delmonte, A. Villeneuve, R. Sladek, F. Xu, et al. (2003) “Identification of a gene causing human cytochrome c oxidase deficiency by Integrative Genomics.” Proceedings of the National Academy of Sciences USA 100: 605–610.

Mukai, J., A. Dhilla, L. J. Drew, K. L. Stark, L. Cao, A. B. MacDermott, M. Karayiorgou, and J. A. Gogos. (2008) “Palmitoylation-Dependent Neurodevelopmental Deficits in a Mouse Model of 22q11 Microdeletion.” Nature Neuroscience 11: 1,302–1,310.

Muller, I., S. Boyle, R. H. Singer, W. A. Bickmore, and J. R. Chubb. (2010) “Stable Morphology, but Dynamic Internal Reorganisation, of Interphase Human Chromosomes in Living Cells.” PLoS One 5: e11,560.

Musunuru, K., A. Strong, M. Frank-Kamenetsky, N. E. Lee, T. Ahfeldt, K. V. Sachs, X. Li, H. Li, N. Kuperwasser, V. M. Ruda, et al. (2010) “From Noncoding Variant to Phenotype Via SORT1 at the 1p13 Cholesterol Locus.” Nature 466: 714–719.

Naj, A. C., G. W. Beecham, E. R. Martin, P. J. Gallins, E. H. Powell, I. Konidari, P. L. Whitehead, G. Cai, V. Haroutunian, W. K. Scott, et al. (2010) “Dementia Revealed: Novel Chromosome 6 Locus for Late-Onset Alzheimer Disease Provides Genetic Evidence for Folate-Pathway Abnormalities.” PLoS Genetics 6: (9). pii: e1001130.

Nakahata, Y., M. Kaluzova, B. Grimaldi, S. Sahar, J. Hirayama, D. Chen, L. P. Guarente, and P. Sassone-Corsi. (2008) “The NAD+–dependent Deacetylase SIRT1 Modulates CLOCK-Mediated Chromatin Remodeling and Circadian Control.” Cell 134: 329–340.

Nakahata, Y., S. Sahar, G. Astarita, M. Kaluzova, and P. Sassone-Corsi. (2009) “Circadian Control of the NAD+ Salvage Pathway by CLOCK-SIRT1.” Science 324: 654–657.

Nan, X., J. Hou, A. Maclean, J. Nasir, M. J. Lafuente, X. Shu, S. Kriaucionis, and A. Bird. (2007) “Interaction Between Chromatin Proteins MECP2 and ATRX Is Disrupted by Mutations That Cause Inherited Mental Retardation.” Proceedings of the National Academy of Sciences USA 104: 2,709–2,714.

Narla, A., and B. L. Ebert. (2010) “Ribosomopathies: Human Disorders of Ribosome Dysfunction.” Blood 115: 3,196–3,205.

Natoli, T. A., L. A. Smith, K. A. Rogers, B. Wang, S. Komarnitsky, Y. Budman, A. Belenky, N. O. Bukanov, W. R. Dackowski, H. Husson, et al. (2010) “Inhibition of Glucosylceramide Accumulation Results in Effective Blockade of Polycystic Kidney Disease in Mouse Models.” Nature Medicine 16: 788–792.

Neumann, M., D. M. Sampathu, L. K. Kwong, A. C. Truax, M. C. Micsenyi, T. T. Chou, J. Bruce, T. Schuck, M. Grossman, C. M. Clark, et al. (2006) “Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis.” Science 314: 130–133.

Ng, S. B., K. J. Buckingham, C. Lee, A. W. Bigham, H. K. Tabor, K. M. Dent, C. D. Huff, P. T. Shannon, E. W. Jabs, D. A. Nickerson, et al. (2010b) “Exome Sequencing Identifies the Cause of a Mendelian Disorder.” Nature Genetics 42: 30–35.

Ng, S. B., D. A. Nickerson, M. J. Bamshad, and J. Shendure. (2010a) “Massively Parallel Sequencing and Rare Disease.” Human Molecular Genetics 19: R1,19–R1,124.

Nguyen, A., T. A. Rauch, G. P. Pfeifer, and V. W. Hu. (2011) “Global Methylation Profiling of Lymphoblastoid Cell Lines Reveals Epigenetic Contributions to Autism Spectrum Disorders and a Novel Autism Candidate Gene, RORA, Whose Protein Product Is Reduced in Autistic Brain.” FASEB Journal 24: 3,036–3,051.

Nicholas, A. K., M. Khurshid, J. Desir, O. P. Carvalho, J. J. Cox, G. Thornton, R. Kausar, M. Ansar, W. Ahmad, A. Verloes, et al. (2010) “WDR62 Is Associated with the Spindle Pole and Is Mutated in Human Microcephaly.” Nature Genetics 42: 1,010–1,014.

Nickerson, M. L., M. B. Warren, J. R. Toro, V. Matrosova, G. Glenn, M. L. Turner, P. Duray, M. Merino, P. Choyke, C. P. Pavlovich, et al. (2002) “Mutations in a Novel Gene Lead to Kidney Tumors, Lung Wall Defects, and Benign Tumors of the Hair Follicle in Patients with the Birt-Hogg-Dube Syndrome.” Cancer Cell 2: 157–164.

Nicodemus, K. K., A. J. Law, E. Radulescu, A. Luna, B. Kolachana, R. Vakkalanka, D. Rujescu, I. Giegling, R. E. Straub, K. McGee, et al. (2010) “Biological Validation of Increased Schizophrenia Risk with NRG1, ERBB4, and AKT1 Epistasis Via Functional Neuroimaging in Healthy Controls.” Archives of General Psychiatry 67: 991–1,001.

Norio, R. (2003) “Finnish Disease Heritage II: Population Prehistory and Genetic Roots of Finns.” Human Genetics 112: 457–469.

Pani, A., A. Mandas, and S. Dessi. (2010) “Cholesterol, Alzheimer’s Disease, Prion Disorders: A Ménage à Trois?” Current Drug Targets 11: 1,018–1,031.

Pantaleo, M. A., G. Nicoletti, C. Nanni, C. Gnocchi, L. Landuzzi, C. Quarta, S. Boschi, M. Nannini, M. Di Battista, P. Castellucci, et al. (2010) “Preclinical Evaluation of KIT/PDGFRA and mTOR Inhibitors in Gastrointestinal Stromal Tumors Using Small Animal FDG PET.” Journal of Experimental and Clinical Cancer Research 29: 173.

Papiol, S., M. Begemann, A. Rosenberger, H. Friedrichs, K. Ribbe, S. Grube, M. H. Schwab, H. Jahn, S. Gunkel, F. Benseler, et al. (2011) “A Phenotype-Based Genetic Association Study Reveals the Contribution of Neuregulin1 Gene Variants to Age of Onset and Positive Symptom Severity in Schizophrenia.” American Journal of Medical Genetics Part B: Neuropsychiatric Genetics (in press).

Patel, K. P., F. Ravandi, D. Ma, A. Paladugu, B. A. Barkoh, L. J. Medeiros, and R. Luthra. (2011) “Acute Myeloid Leukemia with IDH1 or IDH2 Mutation: Frequency and Clinicopathologic Features.” American Journal of Clinical Pathology 135: 35–45.

Peebles, C. L., J. Yoo, M. T. Thwin, J. J. Palop, J. L. Noebels, and S. Finkbeiner. (2010) “Arc Regulates Spine Morphology and Maintains Network Stability In Vivo.” Proceedings of the National Academy of Sciences USA 107: 18,173–18,178.

Peltonen, L., A. Jalanko, and T. Varilo. (1999) “Molecular Genetics of the Finnish Disease Heritage.” Human Molecular Genetics 8: 1,913–1,923.

Pennisi, E. (2010) “Shining a Light on the Genome’s ‘Dark Matter.’” Science 330: 1,614.

Pfeiffer, B. E., and K. M. Huber. (2009) “The State of Synapses in Fragile X Syndrome.” Neuroscientist 15: 549–567.

Phillips, J. E., and V. G. Corces. (2009) “CTCF: Master Weaver of the Genome.” Cell 137: 1,194–1,211.

Pickrell, J. K., J. C. Marioni, A. A. Pai, J. F. Degner, B. E. Engelhardt, E. Nkadori, J. B. Veyrieras, M. Stephens, Y. Gilad, and J. K. Pritchard. (2010) “Understanding Mechanisms Underlying Human Gene Expression Variation with RNA Sequencing.” Nature 464: 768–772.

Pleasance, E. D., P. J. Stephens, S. O’Meara, D. J. McBride, A. Meynert, D. Jones, M. L. Lin, D. Beare, K. W. Lau, C. Greenman, et al. (2010) “A Small-Cell Lung Cancer Genome with Complex Signatures of Tobacco Exposure.” Nature 463: 184–190.

Pleasance, E. D., R. K. Cheetham, P. J. Stephens, D. J. McBride, S. J. Humphray, C. D. Greenman, I. Varela, M. L. Lin, G. R. Ordonez, G. R. Bignell, et al. (2010) “A Comprehensive Catalogue of Somatic Mutations from a Human Cancer Genome.” Nature 463: 191–196.

Polo, J. M., S. Liu, M. E. Figueroa, W. Kulalert, S. Eminli, K. Y. Tan, E. Apostolou, M. Stadtfeld, Y. Li, T. Shioda, et al. (2010) “Cell Type of Origin Influences the Molecular and Functional Properties of Mouse Induced Pluripotent Stem Cells.” Nature Biotechnology 28: 848–855.

Rajendran, L., M. Honsho, T. R. Zahn, P. Keller, K. D. Geiger, P. Verkade, and K. Simons. (2006) “Alzheimer’s Disease Beta-amyloid Peptides Are Released in Association with Exosomes.” Proceedings of the National Academy of Sciences USA 103: 11,172–11,177.

Rasmussen, M., Y. Li, S. Lindgreen, J. S. Pedersen, A. Albrechtsen, I. Moltke, M. Metspalu, E. Metspalu, T. Kivisild, R. Gupta, et al. (2010) “Ancient Human Genome Sequence of an Extinct Palaeo-Eskimo.” Nature 463: 757–762.

Reitman, Z. J., and H. Yan. (2010) “Isocitrate Dehydrogenase 1 and 2 Mutations in Cancer: Alterations at a Crossroads of Cellular Metabolism.” Journal of the National Cancer Institute 102: 932–941.

Riccio, A. (2010) “Dynamic Epigenetic Regulation in Neurons: Enzymes, Stimuli, and Signaling Pathways.” Nature Neuroscience 13: 1,330–1,337.

Roach, J. C., G. Glusman, A. F. Smit, C. D. Huff, R. Hubley, P. T. Shannon, L. Rowen, K. P. Pant, N. Goodman, M. Bamshad, et al. (2010) “Analysis of Genetic Inheritance in a Family Quartet by Whole-Genome Sequencing.” Science 328: 636–639.

Roberts, R. C., A. A. Peden, F. Buss, N. A. Bright, M. Latouche, M. M. Reilly, J. Kendrick-Jones, and J. P. Luzio. (2010) “Mistargeting of SH3TC2 Away from the Recycling Endosome Causes Charcot-Marie-Tooth Disease Type 4C.” Human Molecular Genetics 19: 1,009–1,018.

Rocchi, M., E. D. Green, N. Archidiacano, et al. (2006) “A Preliminary Comparative Analysis of Primate Segmental Duplications Shows Elevated Substitution Rates and a Great-Ape Expansion of Intrachromosomal Duplications.” Genome Research 16: 576–583.

Rochette, J., G. Le Gac, K. Lassoued, C. Ferec, and K. J. Robson. (2010) “Factors Influencing Disease Phenotype and Penetrance in HFE Haemochromatosis.” Human Genetics 128: 233–248.

Rodriguez-Piza, I., Y. Richaud-Patin, R. Vassena, F. Gonzalez, M. J. Barrero, A. Veiga, A. Raya, and J. C. Belmonte. (2010) “Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells Under Xeno-free Conditions.” Stem Cells 28: 36–44.

Rosen, D. R., T. Siddique, D. Patterson, D. A. Figlewicz, P. Sapp, A. Hentati, D. Donaldson, J. Goto, J. P. O’Regan, H. X. Deng, et al. (1993) “Mutations in Cu/Zn Superoxide Dismutase Gene Are Associated with Familial Amyotrophic Lateral Sclerosis.” Nature 362: 59–62.

Ross-Inta, C., A. Omanska-Klusek, S. Wong, C. Barrow, D. Garcia-Arocena, C. Iwahashi, E. Berry-Kravis, R. J. Hagerman, P. J. Hagerman, and C. Giulivi. (2010) “Evidence of Mitochondrial Dysfunction in Fragile X–Associated Tremor/Ataxia Syndrome.” Biochemical Journal 429: 545–552.

Rothfuss, O., H. Fischer, T. Hasegawa, M. Maisel, P. Leitner, F. Miesel, M. Sharma, A. Bornemann, D. Berg, T. Gasser, et al. (2009) “Parkin Protects Mitochondrial Genome Integrity and Supports Mitochondrial DNA Repair.” Human Molecular Genetics 18: 3,832–3,850.

Rothstein, J. D. (2009) “Current Hypotheses for the Underlying Biology of Amyotrophic Lateral Sclerosis.” Annals of Neurology 65, Suppl. 1: S3–S9.

Rudin, C. M., C. L. Hann, J. Laterra, R. L. Yauch, C. A. Callahan, L. Fu, T. Holcomb, J. Stinson, S. E. Gould, B. Coleman, et al. (2009) “Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449.” New Englan Journal of Medicine 361: 1,173–1,178.

Saif, M. W., and E. Chu. (2010) “Biology of Colorectal Cancer.” Cancer Journal 16: 196–201.

Samani, N. J., J. Erdmann, A. S. Hall, C. Hengstenberg, M. Mangino, B. Mayer, R. J. Dixon, T. Meitinger, P. Braund, H. E. Wichmann, et al. (2007) “Genomewide Association Analysis of Coronary Artery Disease.” New England Journal of Medicine, 357: 443–453.

Schayowitz, A., G. Sabnis, V. C. Njar, and A. M. Brodie. (2008) “Synergistic Effect of a Novel Antiandrogen, VN/124-1, and Signal Transduction Inhibitors in Prostate Cancer Progression to Hormone Independence In Vitro.” Molecular Cancer Therapeutics 7: 121–132.

Schmidt, L. S., M. B. Warren, M. L. Nickerson, G. Weirich, V. Matrosova, J. R. Toro, M. L. Turner, P. Duray, M. Merino, S. Hewitt, et al. (2001) “Birt-Hogg-Dube Syndrome, a Genodermatosis Associated with Spontaneous Pneumothorax and Kidney Neoplasia, Maps to Chromosome 17p11.2.” American Journal of Human Genetics 69: 876–882.

Schwab, C., T. Arai, M. Hasegawa, H. Akiyama, S. Yu, and P. L. McGeer. (2009) “TDP-43 Pathology in Familial British Dementia.” Acta Neuropathologica 118: 303–311.

Sebat, J., B. Lakshmi, D. Malhotra, J. Troge, C. Lese-Martin, T. Walsh, B. Yamrom, S. Yoon, A. Krasnitz, J. Kendall, et al. (2007) “Strong Association of De Novo Copy Number Mutations with Autism.” Science 316: 445–449.

Seshadri, S., A. L. Fitzpatrick, M. A. Ikram, A. L. DeStefano, V. Gudnason, M. Boada, J. C. Bis, A. V. Smith, M. M. Carassquillo, J. C. Lambert, et al. (2010) “Genome-wide Analysis of Genetic Loci Associated with Alzheimer Disease.”Journal of the American Medical Association 303: 1,832–1,840.

Shaw, A. T., B. Y. Yeap, M. Mino-Kenudson, S. R. Digumarthy, D. B. Costa, R. S. Heist, B. Solomon, H. Stubbs, S. Admane, U. McDermott, et al. (2009) “Clinical Features and Outcome of Patients with Non-Small-Cell Lung Cancer Who Harbor EML4-ALK.” Journal of Clinical Oncology 27: 4,247–4,253.

She, X., G. Liu, M. Ventura, S. Zhao, D. Misceo, R. Roberto, M.F.Cardone, M. Rocchi M; NISC Comparative Sequencing Program, E.D. Green, N. Archidiacano E.E. Eichler (2006). “A preliminary comparative analysis of primate segmental duplications shows elevated substitution rates and a great-ape expansion of intrachromosomal duplications.” Genome Research. 16(5): 576-83.

Singer, E. (2005) “Personalized Medicine Prompts Push to Redesign Clinical Trials.” Nature Medicine 11: 462.

Small, E. M., and E. N. Olson. (2010) “Pervasive Roles of MicroRNAs in Cardiovascular Biology.” Nature 469: 336–342.

Soda, M., Y. L. Choi, M. Enomoto, S. Takada, Y. Yamashita, S. Ishikawa, S. Fujiwara, H. Watanabe, K. Kurashina, H. Hatanaka, et al. (2007) “Identification of the Transforming EML4-ALK Fusion Gene in Non-Small-Cell Lung Cancer.” Nature 448: 561–566.

Stefansson H, V. Steinthorsdottir, T.E. Thorgeirsson, J.R. Gulcher, K. Stefansson (2004). “Neuregulin 1 and schizophrenia.” Ann Med. 36(1): 62–71.

Steinlein, O. K., and D. Bertrand. (2010) “Nicotinic Receptor Channelopathies and Epilepsy.” Pflugers Archiv 460: 495–503.

Strauss, K. A., E. G. Puffenberger, N. Bunin, N. L. Rider, M. C. Morton, J. T. Eastman III, and D. H. Morton. (2008) “Clinical Application of DNA Microarrays: Molecular Diagnosis and HLA Matching of an Amish Child with Severe Combined Immune Deficiency.” Clinical Immunology 128: 31–38.

Strauss, K. A., and E. G. Puffenberger. (2009) “Genetics, Medicine, and the Plain People.” Annual Review of Genomics and Human Genetics 10: 513–536.

Sudhof, T. C. (2008) “Neuroligins and Neurexins Link Synaptic Function to Cognitive Disease.” Nature 455: 903–911.

Tada, T., and M. Sheng. (2006) “Molecular Mechanisms of Dendritic Spine Morphogenesis.” Current Opinion in Neurobiology 16: 95–101.

Takahashi, R. H., M. Tobiume, Y. Sato, T. Sata, G. K. Gouras, and H. Takahashi. (2010) “Accumulation of Cellular Prion Protein Within Dystrophic Neurites of Amyloid Plaques in the Alzheimer’s Disease Brain.” Neuropathology (in press).

Tennant, D. A., R. V. Duran, and E. Gottlieb. (2010) “Targeting Metabolic Transformation for Cancer Therapy.” Nature Reviews Cancer 10: 267–277.

Thein, S. L., S. Menzel, M. Lathrop, and C. Garner. (2009) “Control of Fetal Hemoglobin: New Insights Emerging from Genomics and Clinical Implications.” Human Molecular Genetics 18: R216–R223.

Thomas, M., J. Lieberman, and A. Lal. (2010) “Desperately Seeking microRNA Targets.” Nature Structural & Molecular Biology 17: 1,169–1,174.

Thompson, A. J., A. J. Muir, M. S. Sulkowski, D. Ge, J. Fellay, K. V. Shianna, T. Urban, N. H. Afdhal, I. M. Jacobson, R. Esteban, et al. (2010) “Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus.” Gastroenterology 139: 120–129 e18.

Tibbetts, A. S., and D. R. Appling. (2010) “Compartmentalization of Mammalian Folate-Mediated One-Carbon Metabolism.” Annual Review of Nutrition 30: 57–81.

Ting, A. K., Y. Chen, L. Wen, D. M. Yin, C. Shen, Y. Tao, X. Liu, W. C. Xiong, and L. Mei. (2011) “Neuregulin 1 Promotes Excitatory Synapse Development and Function in GABAergic Interneurons.” Journal of Neuroscience 31: 15–25.

Tishkoff, S. A., F. A. Reed, F. R. Friedlaender, C. Ehret, A. Ranciaro, A. Froment, J. B. Hirbo, A. A. Awomoyi, J. M. Bodo, O. Doumbo, et al. (2009) “The Genetic Structure and History of Africans and African Americans.” Science 324: 1,035–1,044.

Tomlins, S. A., D. R. Rhodes, S. Perner, S. M. Dhanasekaran, R. Mehra, X. W. Sun, S. Varambally, X. Cao, J. Tchinda, R. Kuefer, et al. (2005) “Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer.” Science 310: 644–648.

Tomlins, S. A., A. Bjartell, A. M. Chinnaiyan, G. Jenster, R. K. Nam, M. A. Rubin, and J. A. Schalken. (2009) “ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice.” European Urology 56: 275–286.

Toro, R., M. Konyukh, R. Delorme, C. Leblond, P. Chaste, F. Fauchereau, M. Coleman, M. Leboyer, C. Gillberg, nd T. Bourgeron. (2010) “Key Role for Gene Dosage and Synaptic Homeostasis in Autism Spectrum Disorders.” Trends in Genetics 26: 363–372.

Tufarelli, C., J. A. Stanley, D. Garrick, J. A. Sharpe, H. Ayyub, W. G. Wood, and D. R. Higgs. (2003) “Transcription of Antisense RNA Leading to Gene Silencing and Methylation As a Novel Cause of Human Genetic Disease.” Nature Genetics 34: 157–165.

Tupler, R., and D. Gabellini. (2004) “Molecular Basis of Facioscapulohumeral Muscular Dystrophy.” Cellular and Molecular Life Sciences 61: 557–566.

Turcotte, S., D. A. Chan, P. D. Sutphin, M. P. Hay, W. A. Denny, and A. J. Giaccia. (2008) “A Molecule Targeting VHL-Deficient Renal Cell Carcinoma That Induces Autophagy.” Cancer Cell 14: 90–102.

van Attikum, H., and S. M. Gasser. (2005) “The Histone Code at DNA Breaks: A Guide to Repair?” Nature Reviews Molecular Cell Biology 6: 757–765.

Vance, C., B. Rogelj, T. Hortobagyi, D. J. De Vos, A. L. Nishimura, J. Sreedharan, X. Hu, B. Smith, D. Ruddy, P. Wright, et al. (2009) “Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6.” Science 323: 1,208–1,211.

Verdin, E., M. D. Hirschey, L. W. Finley, and M. C. Haigis. (2010) “M.C. Sirtuin Regulation of Mitochondria: Energy Production, Apoptosis, and Signaling.” Trends in Biochemical Sciences 35: 669–675.

Vetrivel, K. S., and G. Thinakaran. (2010) “Membrane Rafts in Alzheimer’s Disease Beta-amyloid Production.” Biochimica et Biophysica Acta 1,801: 860–867.

Vierimaa, O., M. Georgitsi, R. Lehtonen, P. Vahteristo, A. Kokko, A. Raitila, K. Tuppurainen, T. M. Ebeling, P. I. Salmela, R. Paschke, et al. (2006) “Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene.” Science 312: 1,228–1,230.

Von Hoff, D. D., P. M. LoRusso, C. M. Rudin, J. C. Reddy, R. L. Yauch, R. Tibes, G. J. Weiss, M. J. Borad, C. L. Hann, J. R. Brahmer, et al. (2009) “Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma.” New England Journal of Medicine 361: 1,164–1,172.

Wacheck, V. (2010) “mTOR Pathway Inhibitors in Cancer Therapy: Moving Past Rapamycin.” Pharmacogenomics 11: 1,189–1,191.

Walker, L. C., H. Levine III, M. P. Mattson, and M. Jucker. (2006) “Inducible Proteopathies.” Trends in Neurosciences 29: 438–443.

Wallace, D. C. (2005) “A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine.” Annual Review of Genetics 39: 359–407.

Walsh, C. T., S. Garneau-Tsodikova, and G. J. Gatto, Jr. (2005) “Protein Posttranslational Modifications: The Chemistry of Proteome Diversifications.” Angewandte Chemie International Edition 44: 7,342–7,372.

Wang, S., R. Wang, L. Chen, D. A. Bennett, D. W. Dickson, and D. S. Wang. (2010) “Expression and Functional Profiling of Neprilysin, Insulin-Degrading Enzyme, and Endothelin-Converting Enzyme in Prospectively Studied Elderly and Alzheimer’s Brain.” Journal of Neurochemistry 115: 47–57.

Wang, D. O., K. C. Martin, and R. S. Zukin. (2010) “Spatially Restricting Gene Expression by Local Translation at Synapses.” Trends in Neurosciences 33: 173–182.

Wang, E. T., R. Sandberg, S. Luo, I. Khrebtukova, L. Zhang, C. Mayr, S. F. Kingsmore, G. P. Schroth, and C. B. Burge. (2008) “Alternative Isoform Regulation in Human Tissue Transcriptomes.” Nature 456: 470–476.

Wang, Z., C. Zang, J. A. Rosenfeld, D. E. Schones, A. Barski, S. Cuddapah, K. Cui, T. Y. Roh, W. Peng, M. Q. Zhang, et al. (2008) “Combinatorial Patterns of Histone Acetylations and Methylations in the Human Genome.” Nature Genetics 40: 897–903.

Wang, Z., M. Gerstein, and M. Snyder. (2009) “RNA-Seq: A Revolutionary Tool for Transcriptomics.” Nature Reviews Genetics 10: 57–63.

Waterhouse, E. G., and B. Xu. (2009) “New Insights into the Role of Brain-Derived Neurotrophic Factor in Synaptic Plasticity.” Molecular and Cellular Neuroscience 42: 81–89.

Weatherall, D. J. (2008). “Genetic Variation and Susceptibility to Infection: The Red Cell and Malaria.” British Journal of Haematology 141 276–286.

Wellen, K. E., G. Hatzivassiliou, U. M. Sachdeva, T. V. Bui, J. R. Cross, and C. B. Thompson. (2009) “ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation.” Science 324: 1,076–1,080.

Whitehead, J., G. K. Pandey, and C. Kanduri. (2009) “Regulation of the Mammalian Epigenome by Long Noncoding RNAs.” Biochimica et Biophysica Acta 1,790: 936–947.

Whittaker, S., R. Marais, and A. X. Zhu. (2010) “The Role of Signaling Pathways in the Development and Treatment of Hepatocellular Carcinoma.” Oncogene 29: 4,989–5,005.

Wiegand, K. C., S. P. Shah, O. M. Al-Agha, Y. Zhao, K. Tse, T. Zeng, J. Senz, M. K. McConechy, M. S. Anglesio, S. E. Kalloger, et al. (2010) “ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas.” New England Journal of Medicine 363: 1,532–1,543.

Wild, E. J., and S. J. Tabrizi. (2007) “Huntington’s Disease Phenocopy Syndromes.” Current Opinion in Neurology 20: 681–687.

Williams, T. N. (2006) “Human Red Blood Cell Polymorphisms and Malaria.” Current Opinion in Microbiology 9: 388–394.

Williams, T. N. (2006) “Red Blood Cell Defects and Malaria.” Molecular and Biochemical Parasitology 149: 121–127.

Wilquet, V., and B. De Strooper. (2004) “Amyloid-beta Precursor Protein Processing in Neurodegeneration.” Current Opinion in Neurobiology 14: 582–588.

Wilson, B. G., X. Wang, X. Shen, E. S. McKenna, M. E. Lemieux, Y. J. Cho, E. C. Koellhoffer, S. L. Pomeroy, S. H. Orkin, and C. W. Roberts. (2010) “Epigenetic Antagonism Between Polycomb and SWI/SNF Complexes During Oncogenic Transformation.” Cancer Cell 18: 316–328.

Wolfe, M. S., and D. J. Selkoe. (2010) “Giving Alzheimer’s the Old One–Two.” Cell 142: 194–196.

Xie, H., V. A. Valera, M. J. Merino, A. M. Amato, S. Signoretti, W. M. Linehan, V. P. Sukhatme, and P. Seth. (2009) “LDH-A Inhibition, a Therapeutic Strategy for Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer.” Molecular Cancer Therapeutics 8: 626–635.

Xiong, H., D. Callaghan, A. Jones, D. G. Walker, L. F. Lue, T. G. Beach, L. I. Sue, J. Woulfe, H. Xu, D. B. Stanimirovic, et al. (2008) “Cholesterol Retention in Alzheimer’s Brain Is Responsible for High Beta- and Gamma-Secretase Activities and Abeta Production.” Neurobiology of Disease 29: 422–437.

Xu, B., J. L. Roos, S. Levy, E. J. van Rensburg, J. A. Gogos, and M. Karayiorgou. (2008) “Strong Association of De Novo Copy Number Mutations with Sporadic Schizophrenia.” Nature Genetics 40: 880–885.

Yachida, S., S. Jones, I. Bozic, T. Antal, R. Leary, B. Fu, M. Kamiyama, R. H. Hruban, J. R. Eshleman, M. A. Nowak, et al. (2010) “Distant Metastasis Occurs Late During the Genetic Evolution of Pancreatic Cancer.” Nature 467: 1,114–1,117.

Yanai, A., K. Huang, R. Kang, R. R. Singaraja, P. Arstikaitis, L. Gan, P. C. Orban, A. Mullard, C. M. Cowan, L. A. Raymond, et al. (2006) “Palmitoylation of huntingtin by HIP14 Is Essential for Its Trafficking and Function.” Nature Neuroscience 9: 824–831.

Yashiro, K., T. T. Riday, K. H. Condon, A. C. Roberts, D. R. Bernardo, R. Prakash, R. J. Weinberg, M. D. Ehlers, and B. D. Philpot. (2009) “Ube3a Is Required for Experience-Dependent Maturation of the Neocortex.” Nature Neuroscience 12: 777–783.

Yauch, R. L., G. J. Dijkgraaf, B. Alicke, T. Januario, C. P. Ahn, T. Holcomb, K. Pujara, J. Stinson, C. A. Callahan, T. Tang, et al. (2009) “Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma.” Science 326: 572–574.

Yu, J., A. Astrinidis, S. Howard, and E. P. Henske. (2004) “Estradiol and Tamoxifen Stimulate LAM-Associated Angiomyolipoma Cell Growth and Activate Both Genomic and Nongenomic Signaling Pathways.” American Journal of Physiology: Lung Cellular and Molecular Physiology 286: L694–L700.

Zempel, H., E. Thies, E. Mandelkow, and E. M. Mandelkow. (2010) “Abeta Oligomers Cause Localized Ca(2+) Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines.” Journal of Neuroscience 30: 11,938–11,950.

Zhao, S., W. Xu, W. Jiang, W. Yu, Y. Lin, T. Zhang, J. Yao, L. Zhou, Y. Zeng, H. Li, et al. (2010) “Regulation of Cellular Metabolism by Protein Lysine Acetylation.” Science 327: 1,000–1,004.

Zhao, W. Q., F. G. De Felice, S. Fernandez, H. Chen, M. P. Lambert, M. J. Quon, G. A. Krafft, and W. L. Klein. (2008) “Amyloid Beta Oligomers Induce Impairment of Neuronal Insulin Receptors.” FASEB Journal 22: 246–260.

Zhou, D., K. Liu, C. W. Sun, K. M. Pawlik, and T. M. Townes. (2010) “KLF1 Regulates BCL11A Expression and Gamma- to Beta-globin Gene Switching.” Nature Genetics 42: 742–744.

Zoncu, R., A. Efeyan, and D. M. Sabatini. (2011) “mTOR: From Growth Signal Integration to Cancer, Diabetes, and Aging.” Nature Reviews Molecular Cell Biology 12: 21–35.